Update search
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Journal
Type
Date
Availability
1-5 of 5
Keywords: Prices
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
The economic and pricing impact of authorized generic medicines in South Africa
Available to Purchase
International Journal of Pharmaceutical and Healthcare Marketing (2015) 9 (1): 20–35.
Published: 07 April 2015
...Shelley-Ann Marion McGee Purpose – This paper aims to examine whether authorized generics (AGs) have influenced prices and market shares in markets for molecules facing generic competition in South Africa. AGs (clones), which are identical to the originator brands, offer a solution for originator...
Journal Articles
Originator and generic medicine: pricing and market share
Available to Purchase
International Journal of Pharmaceutical and Healthcare Marketing (2013) 7 (2): 104–119.
Published: 21 June 2013
...Eon van der Merwe Smit; Jhandré Bredenkamp Purpose The purpose of this paper is to examine the effects of generic medicine competition on the market share growth and pricing of originator brand medicine in the South African private pharmaceutical market. Design/methodology/approach Regression...
Journal Articles
Patients' willingness to pay for diabetes disease state management services in Australian community pharmacies
Available to Purchase
International Journal of Pharmaceutical and Healthcare Marketing (2010) 4 (4): 339–354.
Published: 23 November 2010
... for pharmacy‐delivered disease management support, and how this varies across people with different clinical/socio/demographic characteristics. Diabetes Australia Community health services Prices © Emerald Group Publishing Limited 2010 Patients were provided with a description...
Journal Articles
Are HMO physicians more price sensitive in prescribing brand‐name drugs?
Available to Purchase
International Journal of Pharmaceutical and Healthcare Marketing (2009) 3 (3): 184–209.
Published: 04 September 2009
...Jennifer L. Rice Purpose The purpose of this paper is to estimate whether health maintenance organizations (HMO) physicians are more price sensitive than non‐HMO physicians in their prescribing behavior of brand‐name substitutes. Design/methodology/approach The study uses physician level data...
Journal Articles
Price discrimination by pharmaceutical companies across Central American countries
Available to Purchase
International Journal of Pharmaceutical and Healthcare Marketing (2009) 3 (2): 118–136.
Published: 26 June 2009
...Mariano Rojas Purpose Price becomes a main instrument for rationing pharmaceutical drugs in Central America as a consequence of pro‐market reforms implemented in the 1980s. Under market‐rationing conditions, people's access to branded drugs does depend on their purchasing power and on the vector...
